154 related articles for article (PubMed ID: 18186604)
21. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
22. Antitumor agents 243. Syntheses and cytotoxicity of desmosdumotin C derivatives.
Nakagawa-Goto K; Wu JH; Bastow KF; Wu CC; Lee KH
Bioorg Med Chem; 2005 Mar; 13(6):2325-30. PubMed ID: 15727881
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones.
Deady LW; Rogers ML; Zhuang L; Baguley BC; Denny WA
Bioorg Med Chem; 2005 Feb; 13(4):1341-55. PubMed ID: 15670942
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
[TBL] [Abstract][Full Text] [Related]
25. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships.
Sarek J; Klinot J; Dzubák P; Klinotová E; Nosková V; Krecek V; Korínková G; Thomson JO; Janost'áková A; Wang S; Parsons S; Fischer PM; Zhelev NZ; Hajdúch M
J Med Chem; 2003 Dec; 46(25):5402-15. PubMed ID: 14640549
[TBL] [Abstract][Full Text] [Related]
26. NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin.
Lee CH; Hong H; Shin J; Jung M; Shin I; Yoon J; Lee W
Biochem Biophys Res Commun; 2000 Aug; 274(2):359-69. PubMed ID: 10913344
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action.
Alexander LD; Sellers RP; Davis MR; Ardi VC; Johnson VA; Vasko RC; McAlpine SR
J Med Chem; 2009 Dec; 52(24):7927-30. PubMed ID: 20014866
[TBL] [Abstract][Full Text] [Related]
28. Identification and structure-activity relationship studies of 3-methylene-2-norbornanone as potent anti-proliferative agents presumably working through p53 mediated apoptosis.
Reddy NL; Hill J; Ye L; Fernandes PB; Stout DM
Bioorg Med Chem Lett; 2004 Nov; 14(22):5645-9. PubMed ID: 15482940
[TBL] [Abstract][Full Text] [Related]
29. Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents.
Kuznetsova L; Chen J; Sun L; Wu X; Pepe A; Veith JM; Pera P; Bernacki RJ; Ojima I
Bioorg Med Chem Lett; 2006 Feb; 16(4):974-7. PubMed ID: 16298526
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity study and design of multidrug-resistant reversal compounds by a computer automated structure evaluation methodology.
Klopman G; Srivastava S; Kolossvary I; Epand RF; Ahmed N; Epand RM
Cancer Res; 1992 Aug; 52(15):4121-9. PubMed ID: 1638525
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids.
Kogan NM; Rabinowitz R; Levi P; Gibson D; Sandor P; Schlesinger M; Mechoulam R
J Med Chem; 2004 Jul; 47(15):3800-6. PubMed ID: 15239658
[TBL] [Abstract][Full Text] [Related]
32. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.
Glenn MP; Kahnberg P; Boyle GM; Hansford KA; Hans D; Martyn AC; Parsons PG; Fairlie DP
J Med Chem; 2004 Jun; 47(12):2984-94. PubMed ID: 15163181
[TBL] [Abstract][Full Text] [Related]
34. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening].
Zhukova OS; Dobrynin IaV
Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitumor activity of cis-dichloroplatinum(II) complexes of 1-(2-aminophenyl)-1,2,3,4-tetrahydroisoquinolines.
Kuo CY; Wu MJ; Kuo YH
Eur J Med Chem; 2006 Aug; 41(8):940-9. PubMed ID: 16647164
[TBL] [Abstract][Full Text] [Related]
36. Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study.
Gomes CA; da Cruz TG; Andrade JL; Milhazes N; Borges F; Marques MP
J Med Chem; 2003 Dec; 46(25):5395-401. PubMed ID: 14640548
[TBL] [Abstract][Full Text] [Related]
37. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and comparative molecular field analysis (CoMFA) of argentatin B derivatives as growth inhibitors of human cancer cell lines.
Parra-Delgado H; Compadre CM; Ramírez-Apan T; Muñoz-Fambuena MJ; Compadre RL; Ostrosky-Wegman P; Martínez-Vázquez M
Bioorg Med Chem; 2006 Mar; 14(6):1889-901. PubMed ID: 16289661
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, antitumour activity and structure-activity relationships of 5H-benzo[b]carbazoles.
Asche C; Frank W; Albert A; Kucklaender U
Bioorg Med Chem; 2005 Feb; 13(3):819-37. PubMed ID: 15653349
[TBL] [Abstract][Full Text] [Related]
40. 3-Aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione for circumvention of anticancer drug resistance.
Shchekotikhin AE; Shtil AA; Luzikov YN; Bobrysheva TV; Buyanov VN; Preobrazhenskaya MN
Bioorg Med Chem; 2005 Mar; 13(6):2285-91. PubMed ID: 15727877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
